Dextran-Coated Iron Oxide Nanoparticles as Biomimetic Catalysts for Localized and pH-Activated Biofilm Disruption.
Biofilms
/ drug effects
Biomimetic Materials
/ pharmacology
Catalysis
Cell Line
Dental Caries
/ microbiology
Dextrans
/ chemistry
Ferric Compounds
/ chemistry
Humans
Hydrogen-Ion Concentration
Kinetics
Microbial Viability
/ drug effects
Nanoparticles
/ chemistry
Polysaccharides, Bacterial
/ metabolism
antibacterial
biofilm
dental caries
iron oxide
nanozyme
Journal
ACS nano
ISSN: 1936-086X
Titre abrégé: ACS Nano
Pays: United States
ID NLM: 101313589
Informations de publication
Date de publication:
28 05 2019
28 05 2019
Historique:
pubmed:
16
1
2019
medline:
19
8
2020
entrez:
16
1
2019
Statut:
ppublish
Résumé
Biofilms are surface-attached bacterial communities embedded within an extracellular matrix that create localized and protected microenvironments. Acidogenic oral biofilms can demineralize the enamel-apatite on teeth, causing dental caries (tooth decay). Current antimicrobials have low efficacy and do not target the protective matrix and acidic pH within the biofilm. Recently, catalytic nanoparticles were shown to disrupt biofilms but lacked a stabilizing coating required for clinical applications. Here, we report dextran-coated iron oxide nanoparticles termed nanozymes (Dex-NZM) that display strong catalytic (peroxidase-like) activity at acidic pH values, target biofilms with high specificity, and prevent severe caries without impacting surrounding oral tissues in vivo. Nanoparticle formulations were synthesized with dextran coatings (molecular weights from 1.5 to 40 kDa were used), and their catalytic performance and bioactivity were assessed. We found that 10 kDa dextran coating provided maximal catalytic activity, biofilm uptake, and antibiofilm properties. Mechanistic studies indicated that iron oxide cores are the source of catalytic activity, whereas dextran on the nanoparticle surface provided stability without blocking catalysis. Dextran-coating facilitated NZM incorporation into exopolysaccharides (EPS) structure and binding within biofilms, which activated hydrogen peroxide (H
Identifiants
pubmed: 30642159
doi: 10.1021/acsnano.8b08702
pmc: PMC7059368
mid: NIHMS1054489
doi:
Substances chimiques
Dextrans
0
Ferric Compounds
0
Polysaccharides, Bacterial
0
ferric oxide
1K09F3G675
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4960-4971Subventions
Organisme : NIDCR NIH HHS
ID : R01 DE025848
Pays : United States
Références
Odontology. 2013 Jan;101(1):9-14
pubmed: 23129523
Chemosphere. 2008 Nov;73(9):1524-8
pubmed: 18804842
ACS Nano. 2015 Mar 24;9(3):2255-89
pubmed: 25625290
Curr Drug Deliv. 2014;11(6):719-28
pubmed: 25469778
Carbohydr Res. 2004 Aug 23;339(12):2127-37
pubmed: 15280057
Magn Reson Med. 2016 May;75(5):2107-11
pubmed: 26890830
ISME J. 2018 Jun;12(6):1427-1442
pubmed: 29670217
Appl Environ Microbiol. 2009 Feb;75(3):837-41
pubmed: 19028906
Int J Nanomedicine. 2017 Jul 24;12:5223-5238
pubmed: 28769560
Chem Soc Rev. 2013 Jul 21;42(14):6060-93
pubmed: 23740388
Biomaterials. 2016 Oct;105:127-135
pubmed: 27521615
ACS Nano. 2015 Mar 24;9(3):2390-404
pubmed: 25661192
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
Clin Oral Investig. 2014 May;18(4):1103-1109
pubmed: 24019117
Acc Chem Res. 2011 Oct 18;44(10):842-52
pubmed: 21661727
J Endod. 2018 May;44(5):806-812
pubmed: 29426645
Trends Biotechnol. 2018 Jan;36(1):15-29
pubmed: 29102240
Int J Antimicrob Agents. 2014 Feb;43(2):95-104
pubmed: 24388116
Pharm Bioprocess. 2013 Aug 1;1(3):283-295
pubmed: 24683473
Nat Rev Microbiol. 2017 Dec;15(12):740-755
pubmed: 28944770
Nanoscale. 2014 Mar 7;6(5):2588-93
pubmed: 24468900
Adv Drug Deliv Rev. 2006 Dec 1;58(14):1471-504
pubmed: 17116343
J Bacteriol. 2010 Jun;192(12):3024-32
pubmed: 20233920
J Dent. 2015 Dec;43(12):1483-90
pubmed: 26477347
Nat Nanotechnol. 2007 Sep;2(9):577-83
pubmed: 18654371
Acc Chem Res. 2018 Mar 20;51(3):789-799
pubmed: 29489323
Eur J Orthod. 2017 Feb;39(1):9-16
pubmed: 26787659
Magn Reson Imaging. 1995;13(5):661-74
pubmed: 8569441
Adv Dent Res. 2012 Sep;24(2):53-7
pubmed: 22899680
J Dent Res. 2013 Dec;92(12):1065-73
pubmed: 24045647
Infect Immun. 2014 May;82(5):1968-81
pubmed: 24566629
NMR Biomed. 2013 Jul;26(7):766-80
pubmed: 23303729
Small. 2014 Aug 27;10(16):3354-63
pubmed: 24729432
Bioconjug Chem. 2012 May 16;23(5):941-50
pubmed: 22471239
Ann Biomed Eng. 2014 Nov;42(11):2322-32
pubmed: 24874602
Molecules. 2015 Aug 04;20(8):14155-90
pubmed: 26248071
J Dent. 2014 Aug;42(8):945-51
pubmed: 24930870
Nat Rev Microbiol. 2010 Sep;8(9):623-33
pubmed: 20676145
BMC Microbiol. 2009 Dec 31;9:280
pubmed: 20043840
J Mater Chem B. 2014 Dec 14;2(46):8239-8248
pubmed: 25485115
Arch Oral Biol. 1967 Jan;12(1):11-23
pubmed: 4960207
Nano Lett. 2008 Aug;8(8):2517-25
pubmed: 18624389
Community Dent Oral Epidemiol. 2005 Aug;33(4):248-55
pubmed: 16008631
Nanomedicine. 2008 Sep;4(3):237-40
pubmed: 18565800
ACS Appl Mater Interfaces. 2017 Nov 8;9(44):38270-38280
pubmed: 29020439
Comput Biol Chem. 2017 Oct;70:21-30
pubmed: 28743101
Nanoscale. 2016 Jul 14;8(28):13740-54
pubmed: 27412458
Nanomedicine (Lond). 2017 Feb;12(4):275-279
pubmed: 28093939
J Dent Res. 2015 May;94(5):650-8
pubmed: 25740856
Nat Rev Dis Primers. 2017 May 25;3:17030
pubmed: 28540937
Biomaterials. 2016 Sep;101:272-84
pubmed: 27294544
Clin Pharmacol Ther. 2007 Aug;82(2):204-9
pubmed: 17538551
Nat Nanotechnol. 2010 Aug;5(8):565-9
pubmed: 20581832
Toxicol In Vitro. 2015 Oct;29(7):1445-53
pubmed: 26031843
PLoS Pathog. 2012;8(4):e1002623
pubmed: 22496649